Matches in Wikidata for { <http://www.wikidata.org/entity/Q57065063> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q57065063 description "article" @default.
- Q57065063 description "artículu científicu" @default.
- Q57065063 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57065063 description "wetenschappelijk artikel" @default.
- Q57065063 description "наукова стаття, опублікована у вересні 2018" @default.
- Q57065063 name "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 name "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 type Item @default.
- Q57065063 label "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 label "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 prefLabel "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 prefLabel "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 P1433 Q57065063-0AE01B08-C0AD-4217-BE45-8FF9330689C3 @default.
- Q57065063 P1476 Q57065063-682DD2E2-CC66-49DD-AE15-BFECD5512FAD @default.
- Q57065063 P2093 Q57065063-4702C0CD-5DFD-467B-8B60-7957F7C5C723 @default.
- Q57065063 P2093 Q57065063-678106F5-9945-432C-B9D7-5A997C4DABAD @default.
- Q57065063 P2093 Q57065063-71AEC0B8-3DD9-40B4-AFFA-B088961AD132 @default.
- Q57065063 P2093 Q57065063-F5B82286-2A84-4054-9DCF-DA801DDB3C9B @default.
- Q57065063 P304 Q57065063-0A52E1EF-8E10-4AF4-82FD-9945D024334D @default.
- Q57065063 P31 Q57065063-6C349924-02F4-4FE0-A071-A67E8A26768C @default.
- Q57065063 P356 Q57065063-3F3A5F1F-AA9F-47C8-8141-3E98B418D7B1 @default.
- Q57065063 P407 Q57065063-31CAD13D-7B90-45DE-AC7A-5E8911E1A47A @default.
- Q57065063 P478 Q57065063-C49F6B52-027B-4AA6-B0A9-FF0A0D9F576E @default.
- Q57065063 P577 Q57065063-12EBAD66-7C63-4BD1-B1D9-29AED357F7F2 @default.
- Q57065063 P698 Q57065063-63CBFEDE-1F35-495C-B67A-B0AA49FDEAA5 @default.
- Q57065063 P921 Q57065063-C7BDED35-1BE7-4A66-A214-1D7359D949DB @default.
- Q57065063 P356 J.IJPHARM.2018.09.069 @default.
- Q57065063 P698 30278257 @default.
- Q57065063 P1433 Q6051539 @default.
- Q57065063 P1476 "Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets" @default.
- Q57065063 P2093 "Christoph Konnerth" @default.
- Q57065063 P2093 "Geoffrey Lee" @default.
- Q57065063 P2093 "Veronika Braig" @default.
- Q57065063 P2093 "Wolfgang Peukert" @default.
- Q57065063 P304 "54-60" @default.
- Q57065063 P31 Q13442814 @default.
- Q57065063 P356 "10.1016/J.IJPHARM.2018.09.069" @default.
- Q57065063 P407 Q1860 @default.
- Q57065063 P478 "554" @default.
- Q57065063 P577 "2018-09-29T00:00:00Z" @default.
- Q57065063 P698 "30278257" @default.
- Q57065063 P921 Q1215575 @default.